Cornelia Garz

Vascular dementia

The glymphatic pathway in neurological disorders

The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease

Compromised Blood–Brain Barrier Integrity Is Associated With Total Magnetic Resonance Imaging Burden of Cerebral Small Vessel Disease

NRF2 and NF-қB interplay in cerebrovascular and neurodegenerative disorders: Molecular mechanisms and possible therapeutic approaches

Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders

Pre-clinical models of human cerebral small vessel disease: Utility for clinical application

The Physiological Roles of Amyloid-β Peptide Hint at New Ways to Treat Alzheimer's Disease

Blood-Brain Barrier Breakdown in the Aging Human Hippocampus

Small vessel disease: mechanisms and clinical implications

The Pathobiology of Vascular Dementia

Delayed Increases in Microvascular Pathology after Experimental Traumatic Brain Injury Are Associated with Prolonged Inflammation, Blood–Brain Barrier Disruption, and Progressive White Matter Damage

Understanding the role of the perivascular space in cerebral small vessel disease

F‐domain valency determines outcome of signaling through the angiopoietin pathway

Protective effects of sulforaphane in experimental vascular cognitive impairment: Contribution of the Nrf2 pathway

Blood brain barrier breakdown as the starting point of cerebral small vessel disease? - New insights from a rat model

Vascular basement membrane alterations and β-amyloid accumulations in an animal model of cerebral small vessel disease

Hypertension drives parenchymal β‐amyloid accumulation in the brain parenchyma

The Pathologic Cascade of Cerebrovascular Lesions in SHRSP: Is Erythrocyte Accumulation an Early Phase?

Interplay Between Age, Cerebral Small Vessel Disease, Parenchymal Amyloid-β, and Tau Pathology: Longitudinal Studies in Hypertensive Stroke-Prone Rats